Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Neumora Therapeutics (NMRA): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
10 analysts
Options Flow (P/C)
—
Avg Consensus PT
$6
+1418.6%
Highest Price Target
$14
+3515.7%
Lowest Price Target
$1
+158.3%
Short Interest
6.1%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Jul 13, 2026 | RBC Capital | Brian Abrahams— | +1191.3% | $7 → $5 | Maintained | Outperform |
| Jun 18, 2026 | Mizuho | Graig Suvannavejh— | +933.1% | $6 → $4 | Maintained | Outperform |